ArticleThe Journal of urology2021
Deep Learning Improves Speed and Accuracy of Prostate Gland Segmentations on Magnetic Resonance Imaging for Targeted Biopsy.
Article in The Journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 35 citations in OpenAlex.
- Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validation.European radiology · 2026Article
- Prostate cancer and benign prostatic hyperplasia lesions segmentation using diffusion kurtosis imaging, T2*, and R2* mapping with U-Net++ algorithm.Radiological physics and technology · 2026Article
- Non-Invasive Detection of Prostate Cancer with Novel Time-Dependent Diffusion MRI and AI-Enhanced Quantitative Radiological Interpretation: PROS-TD-AI.Journal of imaging · 2026Article
- AI-driven precision diagnosis and treatment of prostate cancer: a narrative review.Frontiers in oncology · 2026Review
- Artificial intelligence in prostate cancer.Chinese medical journal · 2025Review
- Deep Learning Techniques for Prostate Cancer Analysis and Detection: Survey of the State of the Art.Journal of imaging · 2025Review
- External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens.BJU international · 2025Article
- Review of different convolutional neural networks used in segmentation of prostate during fusion biopsy.Central European journal of urology · 2025Review
- Choosing the right artificial intelligence solutions for your radiology department: key factors to considerDiagnostic and interventional radiology (Ankara, Turkey) · 2024Review
- Catalyzing Precision Medicine: Artificial Intelligence Advancements in Prostate Cancer Diagnosis and Management.Cancers · 2024Review
- RAPHIA: A deep learning pipeline for the registration of MRI and whole-mount histopathology images of the prostate.Computers in biology and medicine · 2024Article
- Deep learning performance on MRI prostate gland segmentation: evaluation of two commercially available algorithms compared with an expert radiologist.Journal of medical imaging (Bellingham, Wash.) · 2024Article
- Article
- Review
- Application of Swarm Intelligence Optimization Algorithms in Image Processing: A Comprehensive Review of Analysis, Synthesis, and Optimization.Biomimetics (Basel, Switzerland) · 2023Review
- Tumor Area Highlighting Using T2WI, ADC Map, and DWI Sequence Fusion on bpMRI Images for Better Prostate Cancer Diagnosis.Life (Basel, Switzerland) · 2023Article
- Article
- Research progress on deep learning in magnetic resonance imaging-based diagnosis and treatment of prostate cancer: a review on the current status and perspectives.Frontiers in oncology · 2023Review
- Correlation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- Domain generalization for prostate segmentation in transrectal ultrasound images: A multi-center study.Medical image analysis · 2022Article
Corrections and comments
- Commented on by
Authors and funding
13 authors at 3 institutions in 2 countries.
Funding
Abstract
purposeTargeted biopsy improves prostate cancer diagnosis. Accurate prostate segmentation on magnetic resonance imaging (MRI) is critical for accurate biopsy. Manual gland segmentation is tedious and time-consuming. We sought to develop a deep learning model to rapidly and accurately segment the prostate on MRI and to implement it as part of routine magnetic resonance-ultrasound fusion biopsy in the clinic. MATERIALS AND
methodsA total of 905 subjects underwent multiparametric MRI at 29 institutions, followed by magnetic resonance-ultrasound fusion biopsy at 1 institution. A urologic oncology expert segmented the prostate on axial T2-weighted MRI scans. We trained a deep learning model, ProGNet, on 805 cases. We retrospectively tested ProGNet on 100 independent internal and 56 external cases. We prospectively implemented ProGNet as part of the fusion biopsy procedure for 11 patients. We compared ProGNet performance to 2 deep learning networks (U-Net and holistically-nested edge detector) and radiology technicians. The Dice similarity coefficient (DSC) was used to measure overlap with expert segmentations. DSCs were compared using paired t-tests.
resultsProGNet (DSC=0.92) outperformed U-Net (DSC=0.85, p <0.0001), holistically-nested edge detector (DSC=0.80, p <0.0001), and radiology technicians (DSC=0.89, p <0.0001) in the retrospective internal test set. In the prospective cohort, ProGNet (DSC=0.93) outperformed radiology technicians (DSC=0.90, p <0.0001). ProGNet took just 35 seconds per case (vs 10 minutes for radiology technicians) to yield a clinically utilizable segmentation file.
conclusionsThis is the first study to employ a deep learning model for prostate gland segmentation for targeted biopsy in routine urological clinical practice, while reporting results and releasing the code online. Prospective and retrospective evaluations revealed increased speed and accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.